Kimberly-Clark to buy Tylenol maker Kenvue for over $40 billion
Kimberly-Clark would be scooping up the former Johnson & Johnson unit after months of struggle.
The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange (NYSE) in New York City, US, May 4, 2023.(photo credit: REUTERS/BRENDAN MCDERMID/FILE PHOTO)ByREUTERSUpdated:
